Blog
RSS FeedPosted by Michael Wonder on 15 Sep 2020
Trump’s last-ditch drug pricing moves could help him in November. But they likely won’t save Americans money.
15 September 2020 - With 50 days to go before the 2020 election, President Trump is taking his wildest swing ...
Posted by Michael Wonder on 15 Sep 2020
Ziopharm Oncology granted rare paediatric disease designation for controlled IL-12 for the treatment of DIPG
14 September 2020 - -- Ziopharm Oncology today announced that the U.S. FDA has granted rare paediatric disease designation to ...
Posted by Michael Wonder on 15 Sep 2020
European Medicines Agency approves safety label update for Novartis Beovu
14 September 2020 - Novartis worked with the EMA to update the Beovu (brolucizumab) label to guide physicians in their treatment ...
Posted by Michael Wonder on 15 Sep 2020
Vertex announces European Medicines Agency type II variation marketing authorisation application validation for Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor in people with one copy of the F508del mutation
14 September 2020 - Vertex Pharmaceuticals today announced the EMA has validated a type II variation marketing authorisation application for ...
Posted by Michael Wonder on 15 Sep 2020
Vaccine maker got $1 billion from taxpayers. Now it’s boosting drug prices.
14 September 2020 - One of the world’s largest drug companies has been aggressively raising prices even as it received ...
Posted by Michael Wonder on 14 Sep 2020
EMA publishes agenda for 14-17 September CHMP meeting
14 September 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 14 Sep 2020
Will Tagrisso win insurance benefits in Korea, too?
14 September 2020 - AstraZeneca’s Tagrisso, targeted therapy for lung cancer, has won recognition as the first-line standard treatment for ...
Posted by Michael Wonder on 14 Sep 2020
Roche drugs chief criticises Trump drug price order, says 'exceeds authority'
15 September 2020 - President Donald Trump’s latest executive order aimed at lowering U.S. drug prices by linking them to ...
Posted by Michael Wonder on 14 Sep 2020
ESSA Pharma announces fast track designation granted by the FDA to EPI-7386 for the treatment of metastatic castration-resistant prostate cancer
14 September 2020 - ESSA Pharma today announced that the US FDA granted fast track designation to EPI-7386, its oral ...
Posted by Michael Wonder on 14 Sep 2020
Sol-Gel Technologies announces FDA acceptance for filing of new drug application for Epsolay for the treatment of inflammatory lesions of rosacea
10 September 2020 - Potential to be first FDA-approved single-agent benzoyl peroxide prescription drug product. ...
Posted by Michael Wonder on 14 Sep 2020
Cancer patients call on Government to fund life-extending medicines
12 September 2020 - Cancer patients are calling on the Government to fund a drug called Cetux. ...
Posted by Michael Wonder on 14 Sep 2020
Mallinckrodt receives a complete response letter from the U.S. FDA for terlipressin for the treatment of hepatorenal syndrome type 1
14 September 2020 - Company remains committed to working with FDA toward an approval for this important potential therapy. ...
Posted by Michael Wonder on 14 Sep 2020
Making best use of big data for public health: publication of the Big Data Steering Group workplan for 2020-21
14 September 2020 - The Big Data Steering Group set up by EMA and the Heads of Medicines Agencies has ...
Posted by Michael Wonder on 14 Sep 2020
FDA grants Dupixent (dupilumab) breakthrough therapy designation for eosinophilic oesophagitis
14 September 2020 - There are currently no FDA approved treatments for this chronic type 2 inflammatory disease that damages the ...
Posted by Michael Wonder on 14 Sep 2020
Evaluation of patient involvement strategies in health technology assessment in Spain: the viewpoint of HTA researchers
11 September 2020 - The Spanish Network of Agencies for Assessing National Health System Technologies and Performance defined a patient involvement ...